Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV003150720 | SCV003838593 | uncertain significance | Cardiomyopathy | 2021-09-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004779493 | SCV005388714 | uncertain significance | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Prevention |
RCV004736317 | SCV005361337 | uncertain significance | TTN-related disorder | 2024-06-27 | no assertion criteria provided | clinical testing | The TTN c.59032A>G variant is predicted to result in the amino acid substitution p.Ile19678Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0056% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |